share_log

Adial Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Schuyler Kevin

SEC ·  Mar 27, 2024 17:10

Summary by Moomoo AI

In a recent transaction dated 03/25/2024, Schuyler Kevin engaged in a stock market activity involving Adial Pharmaceuticals, Inc. (ADIL). The specific details of the transaction, including the number of shares traded, the nature of the shares, the transaction price, and the resulting total value of shares held by Schuyler Kevin after the action, have not been disclosed. The relationship of Schuyler Kevin to the issuer, Adial Pharmaceuticals, was not specified in the announcement.
In a recent transaction dated 03/25/2024, Schuyler Kevin engaged in a stock market activity involving Adial Pharmaceuticals, Inc. (ADIL). The specific details of the transaction, including the number of shares traded, the nature of the shares, the transaction price, and the resulting total value of shares held by Schuyler Kevin after the action, have not been disclosed. The relationship of Schuyler Kevin to the issuer, Adial Pharmaceuticals, was not specified in the announcement.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Heat List
    US
    SymbolLatest Price% Chg

    No Data

    Hot News
    Updated